Ypsomed Holding Toekomstige groei

Future criteriumcontroles 5/6

Ypsomed Holding zal naar verwachting groeien in winst en omzet met respectievelijk 32.9% en 16.3% per jaar. De winst per aandeel zal naar verwachting groeien met 24.7% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 21.5% zijn.

Belangrijke informatie

32.9%

Groei van de winst

24.7%

Groei van de winst per aandeel

Medical Equipment winstgroei	13.9%
Inkomstengroei	16.3%
Toekomstig rendement op eigen vermogen	21.5%
Dekking van analisten	Low
Laatst bijgewerkt	13 Nov 2024

Recente toekomstige groei-updates

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

May 25

Recent updates

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Aug 13

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jul 31

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Jul 03

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Jun 19

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Jun 10

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

May 25

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

May 08

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Apr 07

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Mar 09

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

Feb 07

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Jan 17

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Dec 27

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Nov 24

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Oct 19

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching

Jul 14

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jun 20

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?

Feb 28

Winst- en omzetgroeiprognoses

SWX:YPSN - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CHF Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2027	978	228	-7	348	4
3/31/2026	813	181	-72	291	4
3/31/2025	671	124	-112	205	4
3/31/2024	548	78	-32	163	N/A
12/31/2023	529	75	-37	148	N/A
9/30/2023	509	72	-43	133	N/A
6/30/2023	503	62	-41	131	N/A
3/31/2023	497	51	-40	130	N/A
12/31/2022	492	41	-37	118	N/A
9/30/2022	486	31	-35	107	N/A
6/30/2022	476	27	-38	97	N/A
3/31/2022	465	23	-42	86	N/A
9/30/2021	427	6	-28	90	N/A
6/30/2021	415	6	-28	88	N/A
3/31/2021	404	6	-28	86	N/A
9/30/2020	403	11	-67	60	N/A
6/30/2020	399	11	-69	54	N/A
3/31/2020	394	12	-70	49	N/A
12/31/2019	390	12	-74	44	N/A
9/30/2019	386	12	-78	39	N/A
6/30/2019	420	36	-74	49	N/A
3/31/2019	454	60	-69	60	N/A
12/31/2018	483	72	-51	68	N/A
9/30/2018	511	85	-32	76	N/A
6/30/2018	489	68	-23	65	N/A
3/31/2018	466	52	-14	53	N/A
12/31/2017	442	50	N/A	62	N/A
9/30/2017	418	47	N/A	70	N/A
6/30/2017	404	47	N/A	73	N/A
3/31/2017	390	46	N/A	75	N/A
12/31/2016	377	45	N/A	77	N/A
9/30/2016	365	43	N/A	78	N/A
6/30/2016	351	39	N/A	78	N/A
3/31/2016	337	36	N/A	77	N/A
12/31/2015	326	31	N/A	61	N/A
9/30/2015	316	26	N/A	45	N/A
6/30/2015	311	22	N/A	43	N/A
3/31/2015	307	19	N/A	41	N/A
12/31/2014	300	19	N/A	46	N/A
9/30/2014	293	18	N/A	52	N/A
6/30/2014	285	16	N/A	46	N/A
3/31/2014	276	14	N/A	41	N/A
12/31/2013	266	9	N/A	34	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei YPSN ( 32.9% per jaar) ligt boven de spaarquote ( 0.3% ).

Winst versus markt: De winst van YPSN ( 32.9% per jaar) zal naar verwachting sneller groeien dan de Swiss markt ( 11.2% per jaar).

Hoge groeiwinsten: De winst van YPSN zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van YPSN ( 16.3% per jaar) zal naar verwachting sneller groeien dan de markt Swiss ( 4.1% per jaar).

Hoge groei-inkomsten: De omzet van YPSN ( 16.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen YPSN zal naar verwachting over 3 jaar hoog zijn ( 21.5 %)

Ypsomed Holding Toekomstige groei

Future criteriumcontroles 5/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 7.6% to CHF378

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

Price target increased by 14% to CHF365

Price target increased by 14% to CHF315

Consensus EPS estimates increase by 15%

Price target increased by 13% to CHF257

Recent updates

New minor risk - Share price stability

Ypsomed Group and CamDiab Receives Health Canada Approval for mylife YpsoPump and CamAPS FX and Provide an Enhancing Diabetes Management

Now 23% undervalued

Now 21% undervalued

Ypsomed Holding AG to Report First Half, 2025 Results on Nov 13, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Price target increased by 7.6% to CHF378

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

Full year 2024 earnings released: EPS: CHF5.74 (vs CHF3.82 in FY 2023)

Investor sentiment improves as stock rises 17%

Ypsomed Holding AG to Report Q4, 2024 Results on May 22, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Price target increased by 14% to CHF365

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?

First half 2024 earnings released: EPS: CHF2.68 (vs CHF1.17 in 1H 2023)

Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?

Price target increased by 14% to CHF315

Ypsomed Holding AG to Report First Half, 2024 Results on Nov 15, 2023

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital

Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?

Ypsomed Holding AG, Annual General Meeting, Jun 26, 2024

Upcoming dividend of €1.30 per share at 0.5% yield

Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?

Consensus EPS estimates increase by 15%

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Price target increased by 13% to CHF257

Ypsomed Holding AG to Report Fiscal Year 2023 Results on May 24, 2023

What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital

Ypsomed Holding AG, Annual General Meeting, Jun 28, 2023

At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Price target increased to CHF223

Mediq B.V. completed the acquisition of DiaExpert GmbH from Ypsomed Holding AG (SWX:YPSN).

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Investor sentiment deteriorated over the past week

Now 21% undervalued

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Consensus forecasts updated

Price target increased to CHF207

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

No independent directors

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Price target decreased to CHF192

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching

Upcoming dividend of CHF0.60 per share

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Full year 2022 earnings: EPS in line with analyst expectations despite revenue beat

Ypsomed Holding AG to Report Fiscal Year 2022 Results on May 25, 2022

Price target increased to CHF218

No independent directors

Now 20% undervalued after recent price drop

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?

Now 21% undervalued

Consensus EPS estimates increase by 32%

Now 20% undervalued